MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study

2017156 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 18, Issue 2, pp. 192-201

Field-Weighted Citation Impact: 14.08